Exact Sciences Cor (EXAS)

Apr 22, 2025, 6:00 AM EDT - 1 day ago

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

Apr 14, 2025, 6:00 AM EDT - 9 days ago

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

Apr 1, 2025, 6:00 AM EDT - 22 days ago

Exact Sciences Schedules First Quarter 2025 Earnings Call

Mar 31, 2025, 6:00 AM EDT - 23 days ago

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

Mar 12, 2025, 9:00 AM EDT - 6 weeks ago

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner

Mar 12, 2025, 5:00 AM EDT - 6 weeks ago

New Data Highlight the Positive Impact of Exact Sciences' Oncotype DX® Test on Patient Care and Healthcare Efficiency

Feb 24, 2025, 6:00 AM EST - 2 months ago

Exact Sciences to Participate in March Investor Conferences

Feb 24, 2025, 12:16 AM EST - 2 months ago

Exact Sciences: A Strong Q4 Reveals Signs Of A Potential Inflection Point

Feb 19, 2025, 8:37 PM EST - 2 months ago

Exact Sciences Corporation (EXAS) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 4:05 PM EST - 2 months ago

Exact Sciences Announces Fourth Quarter 2024 Results

Feb 18, 2025, 7:05 AM EST - 2 months ago

U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy's Petition Challenging Validity of a Second Patent Asserted by Exact Sciences

Feb 5, 2025, 8:00 AM EST - 2 months ago

Flatiron Health and Exact Sciences Partner to Advance Clinical Evidence Generation for Molecular Residual Disease Testing

Feb 3, 2025, 6:00 AM EST - 2 months ago

Exact Sciences Schedules Fourth Quarter 2024 Earnings Call

Jan 21, 2025, 5:05 PM EST - 3 months ago

Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium

Jan 21, 2025, 5:05 PM EST - 3 months ago

New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients

Jan 13, 2025, 1:04 PM EST - 3 months ago

Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market

Jan 12, 2025, 7:00 PM EST - 3 months ago

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

Jan 2, 2025, 6:00 AM EST - 3 months ago

Exact Sciences to Participate in J.P. Morgan Healthcare Conference

Dec 9, 2024, 10:01 AM EST - 4 months ago

AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates

Dec 4, 2024, 11:06 AM EST - 5 months ago

Exact Sciences Corporation (EXAS) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)

Dec 3, 2024, 12:02 PM EST - 5 months ago

Exact Sciences Corporation (EXAS) Citi's 2024 Global Healthcare Conference (Transcript)

Dec 2, 2024, 9:30 AM EST - 5 months ago

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Nov 26, 2024, 1:24 PM EST - 5 months ago

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)

Nov 26, 2024, 12:21 PM EST - 5 months ago

Why Is Exact Sciences Stock Trading Higher On Monday?

Nov 26, 2024, 6:00 AM EST - 5 months ago

Exact Sciences to Participate in December Investor Conferences

Nov 25, 2024, 5:35 PM EST - 5 months ago

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024

Nov 19, 2024, 4:07 PM EST - 5 months ago

Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript)

Nov 18, 2024, 8:00 AM EST - 5 months ago

Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community

Nov 13, 2024, 1:00 PM EST - 5 months ago

Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy

Nov 10, 2024, 11:39 AM EST - 5 months ago

Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap.

Nov 6, 2024, 12:36 PM EST - 6 months ago

Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount

Nov 6, 2024, 10:13 AM EST - 6 months ago

Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point

Nov 6, 2024, 7:58 AM EST - 6 months ago

Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HMC SMCI

Nov 5, 2024, 9:06 PM EST - 6 months ago

Exact Sciences Corporation (EXAS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 4:05 PM EST - 6 months ago

Exact Sciences Announces Third-Quarter 2024 Results

Nov 1, 2024, 6:00 AM EDT - 6 months ago

Exact Sciences to Participate in November Investor Conference

Oct 27, 2024, 12:00 PM EDT - 6 months ago

Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement

Oct 8, 2024, 6:00 AM EDT - 7 months ago

Exact Sciences Schedules Third Quarter 2024 Earnings Call

Oct 7, 2024, 2:05 PM EDT - 7 months ago

FMR LLC Bolsters Stake in Exact Sciences Corp

Oct 6, 2024, 2:00 PM EDT - 7 months ago

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

AMGN BIIB BLUE BMY CRSP EDIT NTLA

Oct 4, 2024, 6:00 AM EDT - 7 months ago

FDA Approves Exact Sciences' Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening

Sep 16, 2024, 2:35 AM EDT - 7 months ago

Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024

Sep 12, 2024, 8:21 AM EDT - 7 months ago

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday

Sep 4, 2024, 9:43 PM EDT - 8 months ago

Exact Sciences Corporation (EXAS) at Wells Fargo 2024 Healthcare Conference - Transcript

Aug 28, 2024, 6:00 AM EDT - 8 months ago

Exact Sciences to Participate in September Investor Conferences

Aug 20, 2024, 7:00 AM EDT - 8 months ago

Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study

Aug 18, 2024, 6:51 PM EDT - 8 months ago

Exact Sciences: Cost Optimization And Product Strength

Aug 15, 2024, 7:00 AM EDT - 8 months ago

New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion

Aug 1, 2024, 2:14 PM EDT - 9 months ago

Exact Sciences Analysts Slash Their Forecasts After Q2 Results

Jul 31, 2024, 8:17 PM EDT - 9 months ago

Exact Sciences Corporation (EXAS) Q2 2024 Earnings Call Transcript